Prevalence of Temporomandibular Disorders in Patients With Fibromyalgia Syndrome
1 other identifier
observational
300
1 country
2
Brief Summary
One Hundred Fifty woman patients diagnosed with fibromyalgia according to the American College of Rheumatology 2010 diagnostic criteria and 150 healthy woman volunteers will be included.Demographic data (age, gender, height, weight, marital status, education level) and duration of fibromyalgia diagnosis will be recorded. Patients will be evaluated according to the Diagnostic Criteria for Temporomandibular Disorders: Assessment Instruments (DCTMD: AI ). Patients will be evaluated by Diagnostic Criteria for Temporomandibular Disorders: Temporomandibular Disorders (TMD) Pain Screener, Symptom questionnaire, Clinical Examination Form from Assessment Instruments Axis I. Pain Drawing, Graded Chronic Pain (version 2), Jaw Functional Limitation Scale-8 (JFLS-8), Patient Health Questionnaire (PHQ-4), Oral Behaviors Checklist will be applied within the scope of Axis II.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2021
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2021
CompletedFirst Posted
Study publicly available on registry
April 30, 2021
CompletedStudy Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 27, 2021
CompletedJuly 13, 2022
July 1, 2022
1 month
April 22, 2021
July 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
DCTMD: AI Axis I Pain Screener
TMD Pain Screener which is a simple, reliable, and valid self-report instrument used to assess for the presence of any pain-related TMD, with sensitivity and specificity ≥ 0.95 which is recommended for all patients in any clinical setting. A positive screen is followed by further evaluation to arrive at the specific TMD pain-related diagnoses.
0 DAY
DCTMD: AI Axis I Symptom questionnaire
Symptom questionnaire which assess pain characteristics as well as history of jaw noise, jaw locking, and headache.
0 DAY
DCTMD: AI Axis I Clinical Examination Form
Clinical Examination Form- The clinical examination includes provocation tests for TMJ arthralgia of pain with any jaw movement (ie, opening, lateral, and protrusive) and TMJ palpation. For myalgia, the tests include pain with opening jaw movements and palpation of the temporalis and masseter muscles.
0 DAY
Secondary Outcomes (5)
DCTMD: AI Axis II-Pain Drawing
0 DAY
DCTMD: AI Axis II-Graded Chronic Pain (version 2)
0 DAY
DCTMD: AI Axis II-Jaw Functional Limitation Scale-8 (JFLS-8)
0 DAY
DCTMD: AI Axis II-Patient Health Questionnaire (PHQ-4)
0 DAY
DCTMD: AI Axis II- Oral Behaviors Checklist (OBC)
0 DAY
Study Arms (2)
STUDY GROUP
patient diagnosed with fibromyalgia according to the American College of Rheumatology 2010 diagnostic criteria
CONTROL GROUP
healthy women volunteers
Interventions
Eligibility Criteria
Our study consists of 300 female participants aged between 18 and 65 years who applied to the physical therapy and rehabilitation outpatient clinic.. One Hundred Fifty woman patients diagnosed with fibromyalgia according to the American College of Rheumatology 2010 diagnostic criteria and 150 healthy woman volunteers were included.Because fibromyalgia is a disease that mostly affects women, we designed our study so that all participants were women.
You may qualify if:
- One hundred fifty woman patients diagnosed with fibromyalgia according to the American College of Rheumatology 2010 diagnostic criteria
- One hundred fifty womanhealthy volunteers
You may not qualify if:
- Patients with temporomandibular region surgery
- Congenital teporomandibular joint pathologies
- Previous temporomandibular region trauma were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Basak Cigdem karacay
Yozgat, Yerkoy, 66900, Turkey (Türkiye)
Basak CigdemKaracay
Yozgat, Yerkoy, 66900, Turkey (Türkiye)
Related Publications (3)
Moreno-Fernandez AM, Jimenez-Castellanos E, Iglesias-Linares A, Bueso-Madrid D, Fernandez-Rodriguez A, de Miguel M. Fibromyalgia syndrome and temporomandibular disorders with muscular pain. A review. Mod Rheumatol. 2017 Mar;27(2):210-216. doi: 10.1080/14397595.2016.1221788. Epub 2017 Feb 1.
PMID: 27539739BACKGROUNDFujarra FJ, Kaziyama HH, Siqueira SR, Yeng LT, Camparis CM, Teixeira MJ, Siqueira JT. Temporomandibular disorders in fibromyalgia patients: are there different pain onset? Arq Neuropsiquiatr. 2016 Mar;74(3):195-200. doi: 10.1590/0004-282X20160017.
PMID: 27050847BACKGROUNDPimentel MJ, Gui MS, Martins de Aquino LM, Rizzatti-Barbosa CM. Features of temporomandibular disorders in fibromyalgia syndrome. Cranio. 2013 Jan;31(1):40-5. doi: 10.1179/crn.2013.006.
PMID: 23461261BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Spesialist
Study Record Dates
First Submitted
April 22, 2021
First Posted
April 30, 2021
Study Start
May 1, 2021
Primary Completion
June 1, 2021
Study Completion
August 27, 2021
Last Updated
July 13, 2022
Record last verified: 2022-07